Stocks
Roche Holding (RHHBY) R&D US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D, ₣ | 12 774 000 000 | 13 009 000 000 | 14 799 000 000 | 16 023 000 000 | 14 200 000 000 | 17 966 000 000 | |||
| Changes by years, y/y, % | +6% | +2% | +14% | +8% | -11% | +3.3% | |||
Roche Holding. R&D, ₣
Roche Holding. R&D, changes, %
Roche Holding. R&D, sum by quarters, ₣
Roche Holding (RHHBY) R&D US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D, ₣ | 6 294 000 000 | 3 641 000 000 | 6 937 000 000 | 3 694 000 000 | 3 694 000 000 | 17 966 000 000 | ||
| Changes by years, y/y, % | -17% | -7% | +7% | -41% | ||||
| Changes by quarters, q/q, % | +82% | -42% | +91% | -47% | 0% | |||
